第 1 到 14 筆結果,共 14 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | Current Status of the Spectrum and Therapeutics of Helicobacter pylori-Negative Mucosa-Associated Lymphoid Tissue Lymphoma | SUNG-HSIN KUO ; KUN-HUEI YEH ; CHUNG-WU LIN ; JYH-MING LIOU ; MING-SHIANG WU ; Chen, Li-Tzong; ANN-LII CHENG | Cancers | 9 | 8 | |
2 | 2022 | Treatment of Refractory Helicobacter pylori Infection-Tailored or Empirical Therapy | JYH-MING LIOU ; YI-CHIA LEE ; MING-SHIANG WU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Gut and Liver | 13 | 11 | |
3 | 2021 | The interplay between Helicobacter pylori and gastrointestinal microbiota | CHIEH-CHANG CHEN ; JYH-MING LIOU ; YI-CHIA LEE ; TZU-CHAN HONG ; El-Omar E.M.; MING-SHIANG WU | Gut Microbes | 78 | 42 | |
4 | 2020 | Screening and eradication of Helicobacter pylori for gastric cancer prevention: The Taipei global consensus | JYH-MING LIOU ; Malfertheiner P.; YI-CHIA LEE ; Sheu B.-S.; Sugano K.; Cheng H.-C.; Yeoh K.-G.; Hsu P.-I.; Goh K.-L.; Mahachai V.; Gotoda T.; Chang W.-L.; MEI-JYH CHEN ; TSUNG-HSIEN CHIANG ; CHIEH-CHANG CHEN ; Wu C.-Y.; Leow A.H.-R.; Wu J.-Y.; Wu D.-C.; TZU-CHAN HONG ; Lu H.; Yamaoka Y.; Megraud F.; Chan F.K.L.; Sung J.J.Y.; Lin J.-T.; Graham D.Y.; MING-SHIANG WU ; El-Omar E.M. | Gut | 233 | 187 | |
5 | 2019 | Efficacy and long-term safety of h. Pylori eradication for gastric cancer prevention | JYH-MING LIOU ; YI-CHIA LEE ; El-Omar E.M.; MING-SHIANG WU | Cancers | 31 | 24 | |
6 | 2019 | From germ theory to germ therapy | CHIEH-CHANG CHEN ; YEN-NIEN CHEN ; JYH-MING LIOU ; MING-SHIANG WU ; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Kaohsiung Journal of Medical Sciences | 5 | 5 | |
7 | 2019 | Systematic review and network meta-analysis: Comparative effectiveness of therapies for second-line Helicobacter pylori eradication | Yeo Y.H.; Hsu C.-C.; Lee C.-C.; Ho H.J.; Lin J.-T.; MING-SHIANG WU ; JYH-MING LIOU ; Wu C.-Y.; Taiwan Gastrointestinal Disease; Helicobacter Consortium | Journal of Gastroenterology and Hepatology (Australia) | 25 | 22 | |
8 | 2018 | Toward population specific and personalized treatment of Helicobacter pylori infection | JYH-MING LIOU ; Chen, Po-Yueh; YU-TING KUO ; MING-SHIANG WU | Journal of biomedical science | 28 | 23 | |
9 | 2018 | Systematic review with Meta-Analysis: Concomitant Therapy vs. Triple Therapy for the First-Line Treatment of Helicobacter pylori Infection | MEI-JYH CHEN ; CHIEN-CHUAN CHEN ; YEN-NIEN CHEN ; CHIEH-CHANG CHEN ; YU-JEN FANG ; Lin J.-T.; MING-SHIANG WU ; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | American Journal of Gastroenterology | 32 | 25 | |
10 | 2016 | Treatment of Helicobacter pylori infection: Where are we now? | JYH-MING LIOU ; MING-SHIANG WU ; Lin J.-T. | Journal of Gastroenterology and Hepatology (Australia) | 23 | 20 | |
11 | 2016 | Mass eradication of helicobacter pylori to prevent gastric cancer: Theoretical and practical considerations | YI-CHIA LEE ; TSUNG-HSIEN CHIANG ; JYH-MING LIOU ; Chen, Tony Hsiu Hsi ; MING-SHIANG WU ; Graham D.Y. | Gut and Liver | 45 | 39 | |
12 | 2016 | Systematic review with meta-analysis: the efficacy of levofloxacin triple therapy as the first- or second-line treatments of Helicobacter pylori infection | Chen P.-Y.; MING-SHIANG WU ; Chen C.-Y.; Bair M.-J.; Chou C.-K.; Lin J.-T.; JYH-MING LIOU ; for the Taiwan Gastrointestinal Disease; Helicobacter Consortium | Alimentary Pharmacology and Therapeutics | 60 | 52 | |
13 | 2009 | Think before or sink after: Coosing an appropriate NSAID by balancing gastrointestinal and cardiovascular risks | JYH-MING LIOU ; MING-SHIANG WU ; Lin J.-T. | Journal of the Formosan Medical Association | 1 | 1 | |
14 | 2008 | Helicobacter pylori infection in the elderly | JYH-MING LIOU ; Lin J.-T.; YI-CHIA LEE ; Wu C.-Y.; MING-SHIANG WU | International Journal of Gerontology | 4 | 2 |